Gene Expression Profiling in Rett Syndrome Patients
Author Information
Author(s): Delgado Ivan J, Kim Dong Sun, Thatcher Karen N, LaSalle Janine M, Van den Veyver Ignatia B
Primary Institution: Baylor College of Medicine
Hypothesis
MECP2 mutations result in genome-wide transcriptional deregulation and identify its target genes.
Conclusion
Initial expression profiling from T-cell clones of RTT patients identified a list of potential MeCP2 target genes, but further analysis did not confirm significantly altered expression of most candidate genes.
Supporting Evidence
- 44 genes were found to be upregulated and 77 downregulated in mutant T-lymphocyte clones.
- Expression profiling did not confirm significant changes in most candidate genes.
- SPOCK1 was identified as a potential target gene but showed no significant expression changes in further analyses.
Takeaway
Researchers looked at the genes in T-cells from girls with Rett syndrome to see how MECP2 mutations affect gene activity, but they didn't find strong evidence of changes.
Methodology
Gene expression profiling was performed using oligonucleotide expression microarray analysis on T-lymphocyte clones from patients with specific MECP2 mutations.
Potential Biases
The use of clonal T-lymphocyte cultures may not fully represent the complex gene expression changes in the brain.
Limitations
The study did not confirm significant expression changes in most candidate genes, suggesting potential false positives.
Participant Demographics
Two female patients with classic Rett syndrome, one with a p.T158M mutation and the other with a c.1308-1309delTC mutation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website